Browsing "Rheumatology" by Publication Year :

Jump to a point in the index:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 20 of 219

Publication YearTitleAJOU
Author
2019Clinical characteristics and role of whole-body bone scan in multifocal osteonecrosis안영실박성훈정주양서창희김현아
2019Histopathology and expression of the chemokines CXCL10, CXCL13, and CXCR3 and the endogenous TLR-4 ligand S100A8/A9 in lymph nodes of patients with adult-onset Still's disease김현아권지은한재호
2019Standardized, musculoskeletal ultrasonographic reference values for healthy Korean adults김현아
2019Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians서창희
2019Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study정주양김현아서창희
2019Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial서창희
2019Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study서창희
2019The Liver X Receptor Is Upregulated in Monocyte-Derived Macrophages and Modulates Inflammatory Cytokines Based on LXRalpha Polymorphism김현아정주양서창희
2019Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study서창희정주양부선주
2019The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease정주양서창희김현아
2019Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis정주양김지원김현아서창희
2019Mindfulness-based cognitive therapy in Korean patients with systemic lupus erythematosus: A pilot study김현아정주양조선미서창희
2019A RETROSPECTIVE ANALYSIS OF LONG TERM SAFETY UP TO FIVE YEARS OF INFLIXIMAB BIOSIMILAR CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS서창희
2019CHARACTERIZATION OF SALIVARY PROTEINS IDENTIFIED AS POTENTIAL BIOMARKERS FOR SYSTEMIC LUPUS ERYTHEMATOSUS THROUGH PROTEOMIC ANALYSIS정주양김지원김현아서창희
2019NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO ARE ASSOCIATED WITH DISEASE ACTIVITY IN POLYMYALGIA RHEUMATICA정주양김지원서창희김현아
2019PREVALENCE OF OSTEOPOROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER COMPARATIVE STUDY OF THE FRAX AND WHO CRITERIA김지원정주양김현아서창희
2019Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica정주양서창희김현아
2018Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial서창희
2018Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease정주양서창희김현아손성향
2018Association between brain-derived neurotrophic factor gene polymorphisms and fibromyalgia in a Korean population: a multicenter study김현아
1 2 3 4 5 6 7 8 9 10 11 11

Browse